Chronic Lung Disease in Early Infancy
By: Richard D. Bland (Editor), Jacqueline J. Coalson (Editor)
Hardcover | 21 September 1999 | Edition Number 1
At a Glance
1096 Pages
22.86 x 16.51 x 4.45
Hardcover
RRP $441.00
$312.25
29%OFF
or 4 interest-free payments of $78.06 with
 orÂAvailable for Backorder. We will order this from our supplier however there isn't a current ETA.
This definitive volume presents the clinical and pathological features of bronchopulmonary dysplasia, a disease that accounts for the majority of long-term hospitalizations, slow growth, and recurrent early childhood respiratory ailments that are common in low-birth-weight newborns.
Highlights relevant animal models for studying the process of chronic lung disease through its evolution and during recovery!
Written by nearly 75 leading international authorities on lung disease during early childhood development who describe the clinical, radiographic, and pathological changes that have occurred in the 30 years since bronchopulmonary dysplasia was first discovered, Chronic Lung Disease in Early Infancy
Industry Reviews
Introduction | p. iii |
Preface | p. v |
Contributors | p. vii |
Clinical Aspects | |
Historical Perspective: Early Observations and Subsequent Evolution of Bronchopulmonary Dysplasia | p. 1 |
Introduction and Background | p. 1 |
Historical Perspective | p. 2 |
Early Observations | p. 5 |
The Evolution of BPD | p. 8 |
References | p. 14 |
Epidemiology of Bronchopulmonary Dysplasia: Clinical Risk Factors and Associated Clinical Conditions | p. 21 |
Introduction | p. 21 |
Major Perinatal Clinical Risk Factors for BPD | p. 22 |
Clinical Risk Scoring Systems | p. 29 |
Postnatal Factors That Affect BPD | p. 32 |
Summary | p. 36 |
References | p. 36 |
Clinical Course and Lung Function Abnormalities During Development of Neonatal Chronic Lung Disease | p. 41 |
Introduction | p. 41 |
Definition and Incidence | p. 42 |
Clinical Presentation | p. 43 |
Differential Diagnosis of CLD | p. 53 |
Lung Function During Development of CLD | p. 54 |
Therapeutic Interventions and Lung Function During Development of CLD | p. 57 |
References | p. 59 |
Radiographic Features of BPD and Potential Application of New Imaging Techniques | p. 65 |
Introduction | p. 65 |
The Radiographic Progression of BPD | p. 65 |
BPD as a Chronic Lung Disease | p. 68 |
New Imaging Techniques | p. 72 |
Potential Applications | p. 74 |
References | p. 79 |
Pathology of Chronic Lung Disease of Early Infancy | p. 85 |
Introduction | p. 85 |
Comparison of Classic BPD Pathology with BPD Pathology in the 1990s | p. 86 |
Major Differences in "Old" BPD Versus "New" BPD Pathology: Airway and Interstitial Disease | p. 101 |
Alveolar Hypoplasia and Vascular Dysmorphic Changes: The Consistent Findings in New BPD | p. 108 |
Pathogenesis of BPD in the 1990s | p. 114 |
Summary | p. 117 |
References | p. 118 |
The Usefulness of Bronchoalveolar Lavage in Infants with Evolving Chronic Lung Disease | p. 125 |
Introduction | p. 125 |
General Considerations | p. 126 |
Inflammation: Marker or Protagonist of Injury? | p. 132 |
Clinical Usefulness of BAL in BPD | p. 139 |
Conclusion | p. 140 |
References | p. 141 |
Inflammatory Mediators in Neonatal Lung Disease | p. 147 |
Introduction | p. 147 |
Neutrophils and Macrophages | p. 148 |
Neutrophil and Macrophage Recruitment | p. 149 |
Cytokines | p. 150 |
Elastolytic Damage | p. 152 |
Inflammatory Mediators and Pulmonary Infections | p. 153 |
Pulmonary Protein Leaks | p. 154 |
Oxygen Toxicity | p. 155 |
Conclusions and Outlook | p. 156 |
References | p. 157 |
Infection in the Pathogenesis of Bronchopulmonary Dysplasia | p. 163 |
Introduction | p. 163 |
Epidemiological Correlations | p. 164 |
Pathogenetic Mechanisms | p. 167 |
References | p. 169 |
Ventilation Strategies and Bronchopulmonary Dysplasia | p. 173 |
Introduction | p. 173 |
Barotrauma Versus Volutrauma | p. 174 |
Site of Pathology and Ventilatory Strategy | p. 176 |
Modes of Conventional Ventilators | p. 181 |
High-Frequency Ventilation | p. 183 |
Strategies to Minimize Barotrauma | p. 186 |
Liquid Ventilation | p. 192 |
Weaning from Mechanical Ventilation | p. 195 |
Other Forms of Respiratory Support | p. 196 |
Future Needs | p. 198 |
Summary | p. 199 |
References | p. 200 |
Effect of Respiratory Care Practices on the Development of Bronchopulmonary Dysplasia | p. 209 |
Introduction | p. 209 |
Gas Temperature and Humidity | p. 210 |
Aspiration | p. 229 |
Conclusions | p. 232 |
References | p. 233 |
Influence of Surfactant Replacement on Development of Bronchopulmonary Dysplasia | p. 237 |
Statement of the Question | p. 237 |
Review of the Clinical Data | p. 238 |
Why Should Surfactant Treatments Decrease BPD? | p. 241 |
Why Surfactant Treatment Might Not Affect the Incidence of BPD | p. 246 |
Summary | p. 251 |
References | p. 252 |
Drug Treatment for Established BPD | p. 257 |
Introduction | p. 257 |
Oxygen Therapy | p. 259 |
Diuretic Therapy | p. 260 |
Inhaled Bronchodilator Therapy | p. 264 |
Anti-Inflammatory Therapy | p. 267 |
Nutrition Therapy | p. 269 |
Other Drug Treatments for BPD | p. 272 |
Future Research Directions | p. 273 |
Summary | p. 275 |
References | p. 276 |
Nutritional Issues in Chronic Lung Disease of Premature Infants | p. 285 |
Introduction | p. 285 |
Negative Influence of General Undernutrition and Protein Malnutrition on Oxygen-Induced Lung Injury | p. 286 |
Lipid and Oxygen-Induced Lung Injury: Helpful or Harmful? | p. 287 |
Influence of Additional Nutrients (Inositol, Selenium, and Vitamin A) on Oxygen-Induced Lung Injury | p. 291 |
Conclusion | p. 293 |
References | p. 293 |
Pulmonary Function in BPD and Its Aftermath | p. 297 |
Introduction | p. 297 |
Clinical Evaluation of Infants and Children with BPD | p. 298 |
Growth Failure in Infants with BPD | p. 299 |
Exacerbations with Intercurrent Illness | p. 300 |
Techniques, Interpretation, and Limits of Pulmonary Function Testing in Infants with BPD | p. 301 |
Pulmonary Function in BPD: Infancy and Beyond | p. 306 |
Conclusions and Future Directions | p. 313 |
References | p. 314 |
Cardiovascular Abnormalities in Bronchopulmonary Dysplasia | p. 321 |
Introduction | p. 321 |
Disturbances in Cardiovascular Function | p. 323 |
Therapeutic Strategies | p. 336 |
Summary | p. 346 |
References | p. 346 |
Long-Term Recovery from Bronchopulmonary Dysplasia | p. 357 |
Introduction | p. 357 |
Physical Examination | p. 359 |
Pulmonary Function | p. 359 |
Airway Hyperreactivity | p. 361 |
Radiographic Study of the Chest | p. 362 |
Concluding Remarks | p. 364 |
References | p. 364 |
The Goal: Prevention of BPD | p. 367 |
Introduction | p. 367 |
Predisposing Factors | p. 369 |
References | p. 374 |
Normal and Abnormal Alveolar and Airway Development | |
Unique Features of the Immature Lung That Make It Vulnerable to Injury | p. 377 |
Introduction | p. 377 |
The Airways | p. 378 |
The Parenchyma | p. 387 |
References | p. 396 |
Hormonal Effects on Lung Maturation and Disease | p. 405 |
Introduction | p. 405 |
Prenatal Corticosteroid Therapy and Newborn Lung Disease | p. 406 |
Effects of Thyroid Hormones on Lung Maturation | p. 408 |
Combined Glucocorticoid and Thyroid Hormone Treatment | p. 409 |
Clinical Trials of Antenatal Corticosteroid Plus TRH Therapy | p. 419 |
Summary | p. 422 |
References | p. 423 |
Mechanisms and Physiological Sequelae of Reactive Species Injury to the Alveolar Epithelium | p. 431 |
Introduction and Purpose | p. 431 |
Structure of the Newborn and Adult Alveolar Epithelium | p. 432 |
Oxidant Stress in the Developing Lung | p. 433 |
Biology of Reactive Oxygen and Nitrogen Species | p. 434 |
NO-Derived Effects on the Alveolar Epithelium | p. 439 |
Lesson from Basic Research: Development of Rational Therapeutic Interventions to Limit Oxidant Injury | p. 449 |
References | p. 450 |
Surfactant in Chronic Lung Injury | p. 457 |
Introduction | p. 457 |
Composition and Functions of Pulmonary Surfactant | p. 458 |
Experimental Studies on Surfactant in Chronic Lung Injury | p. 462 |
Involvement of Surfactant in Patients with Chronic Lung Injury | p. 469 |
Conclusions | p. 471 |
References | p. 472 |
The Regulation of the Formation of Pulmonary Alveoli | p. 479 |
Introduction | p. 479 |
Architectural Maturation of the Lung's Gas-Exchange Region: From Saccules to Alveoli | p. 480 |
Formation of Alveoli | p. 481 |
Relation of Experimental Work to the Lung and Its Development in Prematurely Born Infants with Bronchopulmonary Dysplasia | p. 488 |
References | p. 489 |
Factors Mediating Cell Growth in Lung Injury | p. 493 |
Introduction | p. 493 |
Regulation of Cell Division | p. 494 |
Regulation of Normal Lung Growth by Growth Factors | p. 498 |
The Influence of Physical Factors on Lung Cell Growth | p. 503 |
The Influence of Oxygen on Lung Cell Growth | p. 506 |
Epithelial-Mesenchymal Interactions in Lung Injury | p. 509 |
Specific Growth Factors in Lung Injury | p. 510 |
Problems of Interpretation | p. 513 |
Foci for Future Research | p. 514 |
References | p. 515 |
Developmental Airway Structure and Function in Health and Chronic Lung Injury | p. 535 |
Introduction | p. 535 |
Developmental Morphology | p. 536 |
Functional Characteristics of the Immature Airway | p. 547 |
Clinical Assessment of Airway Function | p. 555 |
Summary | p. 561 |
References | p. 562 |
Normal and Abnormal Development of the Lung Circulation and Interstitium | |
Lung Development and the Effects of Chronic Hypoxia | p. 569 |
Introduction | p. 569 |
Normal Development of the Human Lung | p. 569 |
Effect of Chronic Hypoxia on Lung Development | p. 579 |
The Future: Where Do We Go from Here? | p. 589 |
References | p. 591 |
Altered Development of the Pulmonary Circulation in Chronic Lung Injury | p. 597 |
Introduction | p. 597 |
Structural Changes in Pulmonary Arteries | p. 598 |
Acute and Chronic Infection | p. 598 |
Hypoxia | p. 609 |
Oxygen Toxicity and Barotrauma | p. 610 |
High Flow and Pressure | p. 610 |
Chronic Lung Injury: Questions to Be Solved | p. 614 |
References | p. 614 |
Pulmonary Hypertension in Chronic Lung Disease of Infancy: Pathogenesis, Pathophysiology, and Treatment | p. 619 |
Introduction | p. 619 |
Perinatal Pulmonary Circulation: Developmental Aspects | p. 621 |
Effects of Lung Injury on the Developing Pulmonary Circulation | p. 626 |
Pulmonary Hypertension in Premature Neonates with Severe RDS | p. 633 |
Pulmonary Hypertension in CLD of Infancy | p. 636 |
Conclusions and Future Directions | p. 649 |
References | p. 650 |
Connective Tissues in Lung Development and Diseases in Early Infancy | p. 669 |
Introduction | p. 669 |
Extracellular Matrix: General | p. 670 |
ECM Proteins in Lung Development | p. 685 |
Connective Tissue Changes in Lung Diseases of Early Infancy | p. 688 |
Future Directions | p. 695 |
References | p. 697 |
Pulmonary Edema After Premature Birth: Progression from Acute to Chronic Lung Disease | p. 711 |
Introduction | p. 711 |
Lung Fluid Balance During Fetal Development | p. 713 |
Postnatal Lung Fluid Balance | p. 718 |
Lingering Questions | p. 735 |
References | p. 737 |
Mechanisms of Lung Injury and Repair During Development | |
Molecular Mechanisms of Oxygen-Induced Lung Injury | p. 749 |
Introduction | p. 749 |
Possible Roles of Hyperoxic Lung Injury in CLD | p. 750 |
Reactive Oxygen Species in Hyperoxic Lung Injury | p. 753 |
Biomarkers of Reactive Oxygen Species in Biological Systems | p. 754 |
Roles of Iron Metabolism in Reactive Oxygen-Mediated Tissue Injury | p. 768 |
Summary and Conclusions | p. 769 |
References | p. 769 |
Assessment of Tissue Injury from Reactive Oxygen Metabolites | p. 779 |
Introduction | p. 779 |
Methods | p. 783 |
Future Directions | p. 786 |
References | p. 786 |
Chronic Lung Disease of Early Infancy: Role of Neutrophils | p. 793 |
Introduction | p. 793 |
Mechanisms of Neutrophil-Mediated Injury and Recruitment to the Lung | p. 793 |
Pathological and Clinical Studies of Neutrophil Involvement in BPD | p. 796 |
The Role of Neutrophils in Animal Models of BPD | p. 801 |
Conclusions | p. 804 |
References | p. 806 |
The Role of Pulmonary Macrophages in Chronic Lung Disease of Early Infancy | p. 813 |
Introduction | p. 813 |
Emergence of Pulmonary Macrophage Populations and the Pathophysiology of CLD of Early Infancy | p. 814 |
The Role of Pulmonary Macrophages and Lung Infection in the Pathophysiology of CLD of Early Infancy | p. 816 |
Interactions of Lung Macrophages with Other Pulmonary Cells by Direct Cell-to-Cell Communication and Secretory Activity | p. 822 |
Limitations to the Study of Alveolar Macrophages in CLD of Early Infancy and Future Directions | p. 830 |
References | p. 832 |
Oxidants and Antioxidants: What Role Do They Play in Chronic Lung Disease? | p. 841 |
Introduction | p. 841 |
General Principles of Oxidants and Antioxidants | p. 842 |
Evidence Linking Oxygen Radicals and CLD | p. 845 |
Development of the AOE System in the Fetal Lung | p. 845 |
Vulnerability of the Premature Infant Relative to Antioxidant Defenses | p. 847 |
Experimental and Potential Therapeutic Modification of Antioxidant Defenses | p. 849 |
Oxygen Toxicity, Antioxidant Enzymes, and CLD: Unanswered Questions and Future Clinical Applications | p. 852 |
References | p. 853 |
Proteolytic Enzymes and Their Inhibitors in Lung Health and Disease | p. 859 |
Introduction | p. 859 |
Classification of Proteases | p. 860 |
Control of Proteolytic Enzymes | p. 863 |
Functions of Proteolytic Enzymes | p. 868 |
Proteases and Pulmonary Diseases | p. 870 |
Proteases and Chronic Lung Disease of Early Infancy | p. 872 |
What Lies Ahead? | p. 873 |
References | p. 875 |
Site- and Mechanism-Directed Interventions for Tissue Free Radical Injury | p. 883 |
Introduction | p. 883 |
Oxidant-Protective Reactions of Nitric Oxide | p. 884 |
Targeting Catalytic Radical Scavengers to the Extracellular Compartment | p. 890 |
Targeting Catalytic Radical Scavengers to the Intracellular Compartment | p. 894 |
Gene Therapy Strategies for Enhancing Pulmonary Antioxidant Defenses | p. 898 |
Summary | p. 900 |
References | p. 901 |
Models of Lung Injury and Repair During Development | |
Genetic Models for the Study of Autocrine--Paracrine Signaling in Lung Development and Repair | p. 911 |
Introduction | p. 911 |
Role of Fibroblast Growth Factors | p. 912 |
TGF-[alpha] and EGF-R Signaling and Pulmonary Fibrosis and Airspace Remodeling | p. 917 |
Bronchopulmonary Dysplasia | p. 923 |
Summary | p. 924 |
References | p. 924 |
Animal Models of Chronic Lung Injury | p. 927 |
Introduction | p. 927 |
What Is the Human Disease That Needs to Be Modeled? | p. 928 |
Contributors to the Development of BPD | p. 929 |
Potential Uses of Transgenic Models for Future Studies | p. 941 |
Summary and Future Needs | p. 945 |
References | p. 946 |
Author Index | p. 957 |
Subject Index | p. 1043 |
Table of Contents provided by Syndetics. All Rights Reserved. |
ISBN: 9780824798710
ISBN-10: 0824798716
Series: Lung Biology in Health and Disease
Published: 21st September 1999
Format: Hardcover
Language: English
Number of Pages: 1096
Audience: Professional and Scholarly
Publisher: INFORMA MEDICAL
Country of Publication: US
Edition Number: 1
Dimensions (cm): 22.86 x 16.51 x 4.45
Weight (kg): 1.91
Shipping
Standard Shipping | Express Shipping | |
---|---|---|
Metro postcodes: | $9.99 | $14.95 |
Regional postcodes: | $9.99 | $14.95 |
Rural postcodes: | $9.99 | $14.95 |
How to return your order
At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.
Additional postage charges may be applicable.
Defective items
If there is a problem with any of the items received for your order then the Booktopia Customer Care team is ready to assist you.
For more info please visit our Help Centre.
You Can Find This Book In
Smart Foods for ADHD and Brain Health
How Nutrition Influences Cognitive Function, Behaviour and Mood
Paperback
RRP $51.99
$42.95
OFF